A detailed history of Brookstone Capital Management transactions in Becton Dickinson & CO stock. As of the latest transaction made, Brookstone Capital Management holds 14,620 shares of BDX stock, worth $3.28 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
14,620
Previous 13,179 10.93%
Holding current value
$3.28 Million
Previous $3.08 Million 14.42%
% of portfolio
0.06%
Previous 0.06%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$221.47 - $242.41 $319,138 - $349,312
1,441 Added 10.93%
14,620 $3.52 Million
Q2 2024

Jul 18, 2024

BUY
$225.07 - $246.17 $327,251 - $357,931
1,454 Added 12.4%
13,179 $3.08 Million
Q1 2024

Apr 15, 2024

BUY
$233.45 - $247.73 $32,449 - $34,434
139 Added 1.2%
11,725 $2.9 Million
Q4 2023

Jan 11, 2024

BUY
$232.24 - $267.23 $183,237 - $210,844
789 Added 7.31%
11,586 $2.83 Million
Q3 2023

Oct 20, 2023

SELL
$254.9 - $283.59 $1.5 Million - $1.67 Million
-5,904 Reduced 35.35%
10,797 $2.79 Million
Q2 2023

Jul 11, 2023

SELL
$238.39 - $265.32 $26,461 - $29,450
-111 Reduced 0.66%
16,701 $4.41 Million
Q1 2023

Apr 18, 2023

BUY
$229.71 - $259.35 $43,415 - $49,017
189 Added 1.14%
16,812 $4.16 Million
Q4 2022

Jan 09, 2023

BUY
$218.29 - $256.91 $1.46 Million - $1.72 Million
6,687 Added 67.3%
16,623 $0
Q3 2022

Oct 13, 2022

BUY
$51.03 - $264.23 $54,908 - $284,311
1,076 Added 12.14%
9,936 $2.19 Million
Q2 2022

Jul 11, 2022

BUY
$234.74 - $275.42 $1.05 Million - $1.23 Million
4,463 Added 101.5%
8,860 $2.18 Million
Q1 2022

Apr 12, 2022

BUY
$243.64 - $270.48 $593,263 - $658,618
2,435 Added 124.11%
4,397 $1.19 Million
Q4 2021

Jan 11, 2022

BUY
$230.08 - $250.94 $156,224 - $170,388
679 Added 52.92%
1,962 $499,000
Q3 2021

Nov 03, 2021

BUY
$232.72 - $256.47 $298,579 - $329,051
1,283 New
1,283 $308,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Brookstone Capital Management Portfolio

Follow Brookstone Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brookstone Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Brookstone Capital Management with notifications on news.